150 related articles for article (PubMed ID: 2441841)
21. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
22. A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802.
Haas NB; Lin X; Manola J; Pins M; Liu G; McDermott D; Nanus D; Heath E; Wilding G; Dutcher J
Med Oncol; 2012 Jun; 29(2):761-7. PubMed ID: 21298497
[TBL] [Abstract][Full Text] [Related]
23. Sustained response of sarcomatoid renal-cell carcinoma to MAID chemotherapy: case report and review of the literature.
Bangalore N; Bhargava P; Hawkins MJ; Bhargava P
Ann Oncol; 2001 Feb; 12(2):271-4. PubMed ID: 11300337
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors of metastatic renal cell carcinoma with extensive sarcomatoid component.
Park I; Cho YM; Lee JL; Ahn JH; Lee DH; Song C; Hong JH; Kim CS; Ahn H
J Cancer Res Clin Oncol; 2013 May; 139(5):817-27. PubMed ID: 23397357
[TBL] [Abstract][Full Text] [Related]
25. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
[TBL] [Abstract][Full Text] [Related]
26. [Sarcomatoid renal carcinoma].
Leucumberri Castaños D; Podilla Nieva J; Albisu Tristán A; Pertusa Peña CP
Arch Esp Urol; 1998 Oct; 51(8):772-5. PubMed ID: 9859582
[TBL] [Abstract][Full Text] [Related]
27. [A case of renal cell carcinoma similar to rhabdoid tumor of kidney in an adult; trial of radiation and chemotherapy].
Sano K; Kawasaki C; Sato K; Iwasaki A; Ishizuka E
Hinyokika Kiyo; 1991 Dec; 37(12):1699-702. PubMed ID: 1785395
[TBL] [Abstract][Full Text] [Related]
28. Grade 4 unclassified renal cell carcinoma with sarcomatoid component expressing S-100 protein. A case report with peculiar diagnostic and therapeutic implications.
Miolo G; Ash A; Buonadonna A; Lo Re G; Torrisi E; Cervo S; Santeufemia DA; Tuzi A; Canzonieri V
Cancer Biol Ther; 2014; 15(11):1439-43. PubMed ID: 25482943
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology, biology and treatment of sarcomatoid RCC: current state of the art.
Lebacle C; Pooli A; Bessede T; Irani J; Pantuck AJ; Drakaki A
World J Urol; 2019 Jan; 37(1):115-123. PubMed ID: 29858701
[TBL] [Abstract][Full Text] [Related]
30. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
Amin MB; Paner GP; Alvarado-Cabrero I; Young AN; Stricker HJ; Lyles RH; Moch H
Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125
[TBL] [Abstract][Full Text] [Related]
31. [Four cases of sarcomatoid renal cell carcinoma].
Takada T; Kinouchi T; Kinoshita T; Hatano K; Kobayashi M; Inoue H; Hara T; Yamaguchi S
Hinyokika Kiyo; 2009 Feb; 55(2):93-7. PubMed ID: 19301614
[TBL] [Abstract][Full Text] [Related]
32. Chemoimmunotherapy of sarcomatoid renal cell carcinoma.
Krutchik AN; Sullivan C; Sinkovics JG; Ayala A
Med Pediatr Oncol; 1978; 5(1):9-13. PubMed ID: 570634
[TBL] [Abstract][Full Text] [Related]
33. [Renal cell carcinoma in a patient with malignant lymphoma: a case report].
Takagi Y; Senda M; Tanaka J
Hinyokika Kiyo; 2000 Aug; 46(8):545-7. PubMed ID: 11019373
[TBL] [Abstract][Full Text] [Related]
34. [Sarcomatoid renal cell carcinoma: follow-up of a series of 23 patients].
Pamela A; Arnoux V; Long JA; Rambeaud JJ; Lechevallier E
Prog Urol; 2014 Apr; 24(5):301-6. PubMed ID: 24674336
[TBL] [Abstract][Full Text] [Related]
35. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
[TBL] [Abstract][Full Text] [Related]
36. Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors.
Santoni M; Conti A; Partelli S; Porta C; Sternberg CN; Procopio G; Bracarda S; Basso U; De Giorgi U; Derosa L; Rizzo M; Ortega C; Massari F; Iacovelli R; Milella M; Di Lorenzo G; Buti S; Cerbone L; Burattini L; Montironi R; Santini D; Falconi M; Cascinu S
Ann Surg Oncol; 2015; 22(6):2094-100. PubMed ID: 25472645
[TBL] [Abstract][Full Text] [Related]
37. Pathobiology and prognosis of chromophobe renal cell carcinoma.
Klatte T; Han KR; Said JW; Böhm M; Allhoff EP; Kabbinavar FF; Belldegrun AS; Pantuck AJ
Urol Oncol; 2008; 26(6):604-9. PubMed ID: 18367104
[TBL] [Abstract][Full Text] [Related]
38. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice.
Bedke J; Heide J; Ribback S; Rausch S; de Martino M; Scharpf M; Haitel A; Zimmermann U; Pechoel M; Alkhayyat H; Shariat SF; Dombrowski F; Stenzl A; Burchardt M; Klatte T; Kroeger N
BJU Int; 2018 Jan; 121(1):84-92. PubMed ID: 28803448
[TBL] [Abstract][Full Text] [Related]
39. Characteristics and Clinical Outcomes of Sarcomatoid Carcinoma of the Lung.
Ung M; Rouquette I; Filleron T; Taillandy K; Brouchet L; Bennouna J; Delord JP; Milia J; Mazières J
Clin Lung Cancer; 2016 Sep; 17(5):391-397. PubMed ID: 27105684
[TBL] [Abstract][Full Text] [Related]
40. Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation.
Adibi M; Thomas AZ; Borregales LD; Merrill MM; Slack RS; Chen HC; Sircar K; Murugan P; Tamboli P; Jonasch E; Tannir NM; Matin SF; Wood CG; Karam JA
Urol Oncol; 2015 Oct; 33(10):427.e17-23. PubMed ID: 26004164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]